Stefanie Kirchner

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Top Venues

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater

Suicide & life-threatening behavior

European journal of public health

This page only lists publications with an associated author ORCID identifier.

Publications

Stefanie Kirchner, Benedikt Till, Zrinka Laido, Thomas Niederkrotenthaler
Suicide-Related Media Reporting With a Focus on Sexual and Gender Minority Identities. Crisis (2024)
Benedikt Till, Florian Arendt, Stefanie Kirchner, Brigitte Naderer, Thomas Niederkrotenthaler
The role of monocausal versus multicausal explanations of suicide in suicide reporting: A randomized controlled trial. Suicide & life-threatening behavior (2023)
Florian Arendt, Benedikt Till, Martin Voracek, Stefanie Kirchner, Gernot Sonneck, Brigitte Naderer, Paul Pürcher, Thomas Niederkrotenthaler
ChatGPT, Artificial Intelligence, and Suicide Prevention. Crisis 44 (5) (2023)
Magdalena Siegel, Christiana Nöstlinger, Flo Dürrauer, Stefanie Kirchner, Thomas Niederkrotenthaler, Martina Zemp
[Mental health of sexual and gender minority youth in Austria: scoping review and research agenda based on international evidence]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater (2022)
Stefanie Kirchner, Ridwanul Amin, Thomas Niederkrotenthaler, Alexis E Cullen, Katalin Gémes, Magnus Helgesson, Ellenor Mittendorfer-Rutz
Period effects in the risk of labour market marginalization among refugees in Sweden: a register-based cohort study. European journal of public health (2022)
Stefanie Kirchner, Benedikt Till, Martin Plöderl, Thomas Niederkrotenthaler
Effects of "It Gets Better" Suicide Prevention Videos on Youth Identifying as Lesbian, Gay, Bisexual, Transgender, Queer, or Other Sexual or Gender Minorities: A Randomized Controlled Trial. LGBT health 9 (6) (2022)